
Weight-loss drugs like Ozempic and Wegovy are surging in popularity, but that doesn’t mean they’re good for everyone. Glucagon-like peptide-1 receptor agonists (GLP-1RA) may be dangerous for children, warned researchers at University of California, Irvine. Treating childhood obesity and type 2 diabetes with these injected medications may have unintended and adverse consequences in pediatric patients,… read on > read on >